Pluri Inc. Ttl Fee Amt
Pluri Inc. (PLUR) had Ttl Fee Amt of $27.62 thousand as of 2026-09-10, per its S-3 filed 2026-09-11.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-09-11
- 2026-09-10: Ttl Fee Amt $27.62K.
- 2026-09-07: Ttl Fee Amt $44.74.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-09-10 | $27.62K S-3 · filed 2026-09-11 |
| 2026-09-07 | $44.74 S-8 · filed 2026-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |